Matches in SemOpenAlex for { <https://semopenalex.org/work/W52867057> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W52867057 endingPage "5" @default.
- W52867057 startingPage "660" @default.
- W52867057 abstract "Blonanserin was developed in Japan in 2008 as an antipsychotic drug. It has high affinity for dopamine D2/3 and serotonin 5-HT2A receptors, but shows low affinity for adrenergic alpha1, histamine H1, and muscarinic M1 receptors. Several short-term double-blind trials demonstrated that blonanserin was well tolerated and had equal efficacy to haloperidol and risperidone in terms of positive symptoms and depressive symptoms in patients with chronic schizophrenia. It was also superior to haloperidol in improving negative symptoms. We have recently reported that blonanserin may improve some types of cognitive function associated with the frontal lobe activity in patients with first-episode schizophrenia. Taken together, blonanserin may be a promising candidate for a first-line antipsychotic for patients with first-episode and chronic schizophrenia." @default.
- W52867057 created "2016-06-24" @default.
- W52867057 creator A5021387749 @default.
- W52867057 creator A5035627351 @default.
- W52867057 date "2013-04-01" @default.
- W52867057 modified "2023-09-23" @default.
- W52867057 title "[Blonanserin in the treatment of schizophrenia]." @default.
- W52867057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23678596" @default.
- W52867057 hasPublicationYear "2013" @default.
- W52867057 type Work @default.
- W52867057 sameAs 52867057 @default.
- W52867057 citedByCount "0" @default.
- W52867057 crossrefType "journal-article" @default.
- W52867057 hasAuthorship W52867057A5021387749 @default.
- W52867057 hasAuthorship W52867057A5035627351 @default.
- W52867057 hasConcept C118552586 @default.
- W52867057 hasConcept C126322002 @default.
- W52867057 hasConcept C15744967 @default.
- W52867057 hasConcept C2776412080 @default.
- W52867057 hasConcept C2780057945 @default.
- W52867057 hasConcept C2780494398 @default.
- W52867057 hasConcept C2780948584 @default.
- W52867057 hasConcept C44208683 @default.
- W52867057 hasConcept C513476851 @default.
- W52867057 hasConcept C71924100 @default.
- W52867057 hasConcept C98274493 @default.
- W52867057 hasConceptScore W52867057C118552586 @default.
- W52867057 hasConceptScore W52867057C126322002 @default.
- W52867057 hasConceptScore W52867057C15744967 @default.
- W52867057 hasConceptScore W52867057C2776412080 @default.
- W52867057 hasConceptScore W52867057C2780057945 @default.
- W52867057 hasConceptScore W52867057C2780494398 @default.
- W52867057 hasConceptScore W52867057C2780948584 @default.
- W52867057 hasConceptScore W52867057C44208683 @default.
- W52867057 hasConceptScore W52867057C513476851 @default.
- W52867057 hasConceptScore W52867057C71924100 @default.
- W52867057 hasConceptScore W52867057C98274493 @default.
- W52867057 hasIssue "4" @default.
- W52867057 hasLocation W528670571 @default.
- W52867057 hasOpenAccess W52867057 @default.
- W52867057 hasPrimaryLocation W528670571 @default.
- W52867057 hasRelatedWork W1975413208 @default.
- W52867057 hasRelatedWork W1979700184 @default.
- W52867057 hasRelatedWork W2000633119 @default.
- W52867057 hasRelatedWork W2018742347 @default.
- W52867057 hasRelatedWork W2032066744 @default.
- W52867057 hasRelatedWork W2070960090 @default.
- W52867057 hasRelatedWork W2076147139 @default.
- W52867057 hasRelatedWork W2131736555 @default.
- W52867057 hasRelatedWork W2170726480 @default.
- W52867057 hasRelatedWork W2398669402 @default.
- W52867057 hasVolume "71" @default.
- W52867057 isParatext "false" @default.
- W52867057 isRetracted "false" @default.
- W52867057 magId "52867057" @default.
- W52867057 workType "article" @default.